MacroGenics Reports Presentation of Clinical Data at 33rd Annual SITC Meeting

World News: . []

ROCKVILLE MD Nov 09 2018 GLOBE NEWSWIRE -- MacroGenics Inc LINK  MGNX a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the LINK  of cancer toda y annou...

More news and information about MacroGenics, Inc.

Published By:

Globe Newswire: 22:30 GMT Friday 9th November 2018

Published: .

Search for other references to "macrogenics" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us